Literature DB >> 32986241

Multidisciplinary considerations in the treatment of triple-negative breast cancer.

Jennifer R Bellon1,2,3, Harold J Burstein2,3, Elizabeth S Frank2, Elizabeth A Mittendorf2,3,4, Tari A King2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32986241     DOI： 10.3322/caac.21643

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  3 in total

1.  METTL3 Is Suppressed by Circular RNA circMETTL3/miR-34c-3p Signaling and Limits the Tumor Growth and Metastasis in Triple Negative Breast Cancer.

Authors:  Han-Guang Ruan; Wen-Chao Gu; Wen Xia; Yan Gong; Xue-Liang Zhou; Wen-Yan Chen; Juan Xiong
Journal:  Front Oncol       Date:  2021-12-22       Impact factor: 6.244

2.  Screening of Specific and Common Pathways in Breast Cancer Cell Lines MCF-7 and MDA-MB-231 Treated with Chlorophyllides Composites.

Authors:  Keng-Shiang Huang; Yi-Ting Wang; Omkar Byadgi; Ting-Yu Huang; Mi-Hsueh Tai; Jei-Fu Shaw; Chih-Hui Yang
Journal:  Molecules       Date:  2022-06-20       Impact factor: 4.927

3.  Application of mammography-based radiomics signature for preoperative prediction of triple-negative breast cancer.

Authors:  Shuai Ge; Yu Yixing; Dong Jia; Yang Ling
Journal:  BMC Med Imaging       Date:  2022-09-14       Impact factor: 2.795
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.